(Q37867782)

24 August 2017

1 reference

title

Stroke and the immune system: from pathophysiology to new therapeutic strategies (English)

1 reference

24 August 2017

1 reference

6

1 reference

24 August 2017

Denis Vivien

7

0 references

Carine Ali

object named as

Carine Ali

series ordinal

2

0 references

Richard Macrez

series ordinal

1

object named as

Richard Macrez

1 reference

24 August 2017

4

Brigitte Le Mauff

1 reference

24 August 2017

Olivier Toutirais

3

1 reference

PubMed ID

21511199

24 August 2017

Gilles Defer

series ordinal

5

1 reference

24 August 2017

1 May 2011

1 reference

24 August 2017

1 reference

24 August 2017

10

1 reference

24 August 2017

5

1 reference

24 August 2017

471-480

1 reference

Neuroprotection and stroke: time for a compromise

24 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Lipoxin A4 analogue protects brain and reduces inflammation in a rat model of focal cerebral ischemia reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Protective Role of Reactive Astrocytes in Brain Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Microglia provide neuroprotection after ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Acute ischaemic stroke and infection: recent and emerging concepts

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Models of infection before and after stroke: investigating new targets

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Chagas disease and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Stroke in HIV infection and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Virus vasculopathy and stroke: an under-recognized cause and treatment target

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Common infections and the risk of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Infectious burden: a new risk factor and treatment target for atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Rashes, sniffles, and stroke: a role for infection in ischemic stroke of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Acute ischemic stroke and infections

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Antibodies to Chlamydia pneumoniae are associated with increased intima media thickness in asymptomatic Indian individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Inflammatory mechanisms of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

The Role of Immunity and Inflammation in the Progression of Atherosclerosis in Patients With HIV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Prolonged, 24-h delayed peripheral inflammation increases short- and long-term functional impairment and histopathological damage after focal ischemia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Increased neuronal proliferation in human bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Measles virus nucleoprotein induces a regulatory immune response and reduces atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Decreased infarct size after focal cerebral ischemia in mice chronically infected with Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Mild systemic inflammation has a neuroprotective effect after stroke in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Endotoxin preconditioning prevents cellular inflammatory response during ischemic neuroprotection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Improving outcome after stroke: overcoming the translational roadblock

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Inflammation, plasticity and real-time imaging after cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Sterile inflammation: sensing and reacting to damage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Toll-like receptor signaling in endogenous neuroprotection and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

It's all in the family: multiple Toll-like receptors offer promise as novel therapeutic targets for stroke neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

The HMGB1 receptor RAGE mediates ischemic brain damage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Inhibition of reactive astrocytes with fluorocitrate retards neurovascular remodeling and recovery after focal cerebral ischemia in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Post-ischemic brain damage: pathophysiology and role of inflammatory mediators.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Interleukin-1 and neuronal injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Rapid brain penetration of interleukin-1 receptor antagonist in rat cerebral ischaemia: pharmacokinetics, distribution, protection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Signaling by death receptors in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

The many faces of tumor necrosis factor in stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Inflammatory mechanisms in ischemic stroke: role of inflammatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Temporal and spatial dynamics of cerebral immune cell accumulation in stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

1 reference

7 January 2021

Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Proliferating resident microglia after focal cerebral ischaemia in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Microglial involvement in neuroplastic changes following focal brain ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Central nervous system injury-induced immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Stroke-induced immunodepression: experimental evidence and clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Modulation of the postischemic immune response to improve stroke outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Post-stroke immunodepression and infection: an emerging concept

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Stroke induced immunodepression syndrome: from bench to bedside

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Detrimental consequences of brain injury on peripheral cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Stress system--organization, physiology and immunoregulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Early predictors of death and disability after acute cerebral ischemic event

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Immunological observations on patients with acute cerebral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Harms and benefits of lymphocyte subpopulations in patients with acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Catecholamines, infection, and death in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Lymphocytes: potential mediators of postischemic injury and neuroprotection.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Sensitization and tolerization to brain antigens in stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

From inflammation to sickness and depression: when the immune system subjugates the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Randomized double-blind placebo-controlled study of an angiotensin immunotherapeutic vaccine (PMD3117) in hypertensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: a double-blind, randomised, placebo-controlled phase IIa study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Success and failure of vaccines against renin-angiotensin system components

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Association between influenza vaccination and reduced risk of brain infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Chronic bronchitis and acute infections as new risk factors for ischemic stroke and the lack of protection offered by the influenza vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Influenza and stroke risk: a key target not to be missed?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Intracranial hemorrhage following thrombolytic use for stroke caused by infective endocarditis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Elevated soluble intercellular adhesion molecule-1 levels are associated with poor short-term prognosis in middle-aged patients with acute ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

The expression of P- and E-selectins in three models of middle cerebral artery occlusion.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Monitoring the protective effects of minocycline treatment with radiolabeled annexin V in an experimental model of focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Minocycline as a neuroprotective agent

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Extension of the thrombolytic time window with minocycline in experimental stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Minocycline treatment in acute stroke: an open-label, evaluator-blinded study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Functional occurrence of the interaction of tissue plasminogen activator with the NR1 Subunit of N-methyl-D-aspartate receptors during stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Bench to bedside: the quest for quality in experimental stroke research

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Enhancing the Development and Approval of Acute Stroke Therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Preparing for first-in-man studies: the challenges for translational immunology post-TGN1412.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Cerebral amyloid angiopathy and microhemorrhages after amyloid beta vaccination: case report and brief review.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Multiphasic roles for matrix metalloproteinases after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Effects of acute post-treatment with dipyridamole in a rat model of focal cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Amelioration of inflammation and cytotoxicity by dipyridamole in brain endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

TeGenero fiasco prompts regulatory rethink

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

Systems approach to inflammation resolution: identification of novel anti-inflammatory and pro-resolving mediators

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2811%2970066-7

7 January 2021

10.1016/S1474-4422(11)70066-7

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21511199